Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2015 Aug 6;2(9):1008-9.
doi: 10.1016/j.ebiom.2015.08.007. eCollection 2015 Sep.

The Japan Statin Treatment Against Recurrent Stroke (J-STARS) Trial: Where to Now?

Affiliations
Editorial

The Japan Statin Treatment Against Recurrent Stroke (J-STARS) Trial: Where to Now?

Graeme J Hankey. EBioMedicine. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Cholesterol Treatment Trialists' (CTT) Collaboration Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet. 2015;385:1397–1405. - PubMed
    1. Cholesterol Treatment Trialists' (CTT) Collaboration Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376:1670–1681. - PMC - PubMed
    1. Heart Protection Study Collaborative Group Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20,536 people with cerebrovascular disease or other high-risk conditions. Lancet. 2004;363:757–767. - PubMed
    1. Hosomi N., Nagai Y., Kohriyama T., Ohtsuki T., Aoki A., Nezu T. The Japan Statin Treatment Against Recurrent Stroke (J-STARS): a multicentre, randomized, open-label, parallel group study. EBioMedicine. 2015;2:1071–1078. - PMC - PubMed
    1. Manktelow B.N., Potter J.F. Interventions in the management of serum lipids for preventing stroke recurrence. Cochrane Database Syst. Rev. 2009;3:CD002091. - PubMed

MeSH terms

Substances